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Abstract
Background: A comfortable postoperative return to daily activities has increased the need to control inflammation
after third molar surgery. Anti-inflammatory drugs and analgesics are not exempt from adverse effects such as
allergies and chronic gastritis, and they are not without cost. The association between low-level laser and auricular
acupuncture can be an alternative when conventional drugs are contraindicated. Among its advantages, we can
mention the low risk of side effects, low cost and simplicity of application. The objective of this study is to evaluate
the efficiency of low-level laser at auriculotherapy points in reducing postoperative pain in lower third molar
surgery.
Methods/design: Ninety bilateral, symmetrical lower third molar surgeries will be performed in 45 healthy
patients. Each patient will be their own control, through a split-mouth crossover study. One side of the
mouth will be randomly chosen and, immediately after surgery, will be treated with low-level laser. After 21
days, the contralateral side will be operated on with low-level laser simulation used postoperatively. This
regimen (laser application or not) will be repeated at 24 and 48 h after surgery. All patients will be
requested to take analgesics (acetaminophen) if they have pain, i.e. in case of pain. Neither the surgeon
nor the patients will know the assigned treatment. The primary variable will be postoperative pain assessed
using a Visual Analog Scale, and the secondary variables will be trismus, edema, local temperature,
dysphagia, presence of infection and painkiller ingestion. These variables will be assessed at baseline, 24 h,
48 h and 7 days after surgery. Blood samples for systemic inflammatory cytokine (TNF-α, IL-1, IL-6 and IL-8)
analysis will be assessed at baseline and 24 h after surgery.
Discussion: Some authors believe that using a wavelength of 633 to 670 nm is a good option for laser
therapy in the field of acupuncture. This wavelength can penetrate biological tissue to a depth of about 3
mm. However, for auriculotherapy points, the stimulus (mustard seeds, needles 1 to 2.5 mm) does not
penetrate so deeply. For this reason, we chose a laser wavelength of 660 nm (red wavelength).
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Background
Third molar surgery is the most common surgical
procedure in dentistry. The postoperative period of
third molar surgery is usually accompanied by pain,
trismus and swelling, and controlling these symptoms
is essential for patient comfort. An inflammatory re-
action followed by phlogistic symptoms are common
and compromise the quality of life of patients during
the first 3 days after surgery [1–3], and about 63 %
of patients feel intense pain during the first day after
surgery, with greater intensity 3–5 h after the end of
anesthesia [4]. Among complications after this type of
surgery are alveolar osteitis (dry socket) abscess, fever,
reactive lymph node pathology and fever, among
others already mentioned [5]. The need for a com-
fortable postoperative recovery and a rapid return to
daily activities has increased the importance of con-
trolling postoperative inflammation, especially with re-
spect to pain and edema. Currently, control of pain
and inflammation is conducted with corticosteroids
and nonsteroidal anti-inflammatory drugs (NSAIDs)
[4, 6, 7]. Anti-inflammatory drugs are often prescribed
preventatively and in the postoperative period [4].
However, some studies have shown adverse reactions
to NSAIDs, such as gastrointestinal disorders
(erosions, ulcers, dyspepsia) with serious bleeding
complications, increased cardiovascular complications,
kidney failure and platelet alterations [8, 9]. Some
studies have discussed the value of auriculotherapy
with low-level laser, as well as the benefits of biomo-
dulation in the inflammatory process, working mainly
on symptoms such as pain and swelling [10–12].
Some studies have shown that traditional acupuncture
is able to interfere with the regulation of both sys-
temic (e.g., interleukin (IL)-10, IL-4) and pro-
inflammatory markers (IL-6, IL-1β, tumor necrosis
factor alpha (TNF-α)) in some diseases such as
asthma and rhinitis [13]. In turn, third molar surgery
increases the level of interleukins, especially IL-6,
after surgical trauma [14]. This surgical procedure is
considered the “gold standard” in pain studies [2, 4]
but the behavior of systemic inflammatory markers
has not been evaluated after auriculotherapy following
third molar extraction.
Acupuncture is an integral part of a system called
Traditional Chinese Medicine. According to the
World Health Organization (WHO) it stimulates cer-
tain points that are distributed throughout the body’s
surface using needles, moxibustion, electricity, laser
or acupressure [15, 16]. It has been used for many
years in several areas of health, but further studies
are needed [10, 11, 15, 17–20]. Auriculotherapy or
ear acupuncture is one of the acupuncture modalities.
Auricular acupuncture can be defined as a system of
diagnosis and treatment based on normalization of
dysfunctions in the body by stimulating points located
on the ear [6, 20], or a therapeutic intervention where
stimuli to the external ear are used to relieve health
problems in various parts of the body [21]. Auricular
therapy can be understood from two perspectives: an-
cient auricular acupuncture and modern ear acupunc-
ture. The first is based on the stimulation of
acupuncture points in the auricle that are connected
to the meridians of the body. It is used primarily for
the resolution of pain (Chinese School). The second
is Paul Nogier’s School, which presupposes a somato-
tropic organization, representing the whole body in
the human ear (European School) [18]. There are sev-
eral propositions for the theoretical foundations of
auriculotherapy. Among them, we can mention the
neurological theory, the embryological theory, micro-
systems, the energy theory of Traditional Chinese
Medicine and the hormonal basis [21]. In 1982, the
WHO developed a working group aiming to
standardize research and clinical uses of auriculother-
apy [22]. It intended to establish classification criteria,
location and therapeutic value of the points. Despite
its efforts, there are still many discrepancies between
the two schools described above.
There is only one clinical study to date that evalu-
ates the effect of laser therapy to auricular points for
pain reduction in dentistry [23], and there are no ran-
domized controlled clinical trials that validate the ef-
fectiveness of auriculotherapy associated with low-
level laser to control pain, swelling and postoperative
inflammation. In this study, the authors describe a
protocol designed to evaluate the application of
helium-neon laser or sham to auriculotherapy points
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after third molar surgery to reduce pain and
inflammation.
Methods/design
The protocol was approved by the Research Ethics Com-
mittee of Nove de Julho University (UNINOVE), number
#1100869. This study had all necessary consent approved
by Nove de Julho University Ethical Committee for any
patients who will be involved in the study, including an
Informed Consent Form that patients will need to sign to
participate. The study is in accordance with the Declar-
ation of Helsinki. Patients who accept participation will
sign the Informed Consent Form after verbal (by HSF)
and written explanation of the study. The sample will
comprise 45 healthy patients of both genders aged from
18 to 28 years who require surgical removal of bilateral
symmetrical lower third molars. Patients will undergo two
surgeries with a 21-day interval between them in a split-
mouth crossover design. The surgeries will be performed
by the same surgeon in the Dental Clinic at Nove de Julho
University, São Paulo, Brazil, from June 2016 until Febru-
ary 2017.
Sample size calculation
The sample size was calculated (G* Power software ver-
sion 3.1.9.2) by a t test for paired groups, since we have
two groups (right side and left side) on the same patient.






We select the worst scenario, that is, the largest stand-
ard deviation (SD) between means. The mean values of
control and treated groups, as well as the SD were taken
from one particular study [24]. The error was set at 5 %
and the power test at 95 %. According to the calculation,
a sample of 45 patients will be necessary to detect differ-
ences in pain.
Inclusion and exclusion criteria
The study will include healthy patients (negative
medical history) with their teeth in position IIB ac-
cording to Pell and Gregory [25], with an indication
for the extraction of their third molars (recurrent in-
fections, poor position, orthodontic indication) or
professional referral in writing. The following pa-
tients will be excluded: those allergic to any drug
used in the research (paracetamol (acetaminophen),
2 % chlorhexidine), pregnant or breastfeeding
women, smokers, those who have undergone radio-
therapy to the head and neck, systemic or local in-
fection (e.g., pericoronitis or periodontal abscess),
and those with injuries or radiolucent images
associated with the extracted teeth. Patients who
have used anti-inflammatory drugs in the last 3
months, and patients who present any complications
during surgery (e.g., bleeding, surgical difficulty, sur-
gery longer than 90 min) will also be excluded.
Randomization
An external researcher, who will not participate in this
research (IPT), will perform randomization using Micro-
soft Excel, 2013 version. As the letters are drawn (A or
B), they will be placed into opaque envelopes labeled
with sequential numbers. The envelopes will be sealed
and remain in numerical order in a safe place until the
completion of surgery. The same researcher (IPT) (not
involved in the study) will prepare the envelopes. To de-
cide the side of intervention, we will randomize into 45
blocks (1:1) of 90 surgeries designed as A or B. This cor-
responds to 45 blocks, either AB or BA. As the study
will be performed in a double-blind manner, neither the
patient nor the operator will know which treatment will
be applied in each of the two surgeries. The only person
who will know the treatment performed (JSR) will be
the researcher who is responsible for the application of
the laser to the auriculotherapy points. This data will
only be revealed after statistical analysis.
Design
This is a controlled, randomized, double-blind, split-
mouth, crossover clinical trial. In a split-mouth study, a
patient functions as their own control:
G1 – (experimental) 45 third molar surgeries will be
performed in a conventional manner [26]. At the end
of surgery, low-level laser will be applied to auricular
points for prevention of inflammation and pain in the
immediate postoperative period and after 24 and 48 h
after surgery.
G2 – (control) 45 surgeries will be performed in the
conventional manner, identical to G1. The patient will
receive low-level laser, albeit turned off in order to
block the passage of light, to the same auricular points
used in G1.
The surgeries will be performed with two cartridges
(1.8 mL) of the local anesthetic (LA) mepivacaine 2 %
with epinephrine 1:1,000,000. The time delay between
the surgery on each side will be 21 days.
Acetaminophen (750 mg) 8/8 h will be provided for all
patients. They will be instructed to use this only in case
of pain, and only for 3 days.
A medical prescription for acetaminophen with co-
deine phosphate 30 mg (Tylex® Janssen-Cilag) will be
provided only in case of severe pain. Patients who need
to use this will be excluded from the study. Data from
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these patients will only be described, but not included in
the analysis of results. This exclusion will not jeopardize
their treatment for ethical reasons. Any adverse event
will be reported in the study. Any important protocol
modifications will be communicated.
Methodology for application of auriculotherapy points
The researcher who will apply the laser will mark the
points that will be irradiated on the outer atrium of the
patient’s ear with a red gel pen to avoid interference with
red laser light (λ = 660 nm). The low-level laser points
will be irradiated on the same operated side, based on
Oleson [21]; see Fig. 1. The marking of points will be
confirmed objectively by a point locator, the Acupoint
detector (Acupoint detector MH – II®, Japan) for aur-
iculotherapy, which measures point impedance [27].
Rationale for the choice of auriculotherapy points
The World Federation of Acupuncture and Moxibustion
Societies (WFAS), F7, B Dongjiu Mansion, Xizhaosi street,
Dong Cheng District, Beijing. 100061, China. TEL: 86-10-
64011210, 10.1186/s13063-016-1540-9 FAX: 86-10-64018354
E-mail: wfas1987@foxmail.com, owing to the fact that
there are numerous classifications and auriculotherapy
maps used in several countries, has established some norms
for the standardization of auricular acupuncture points by
bringing together experts who promoted the so-called
ISAAPs (International Standard of Auricular Acupuncture
Points) [28]. The naming and location was based on subdi-
visions and models proposed by Oleson [21].
The points to be used in this study are listed below
along with their main function: (1) Shen Men – relieves
pain, anxiety and inflammatory diseases, (2) Sympathetic
– SNV – activation by the sympathetic nervous system
of parasympathetic sedation, reducing neurovegetative
imbalance, (3) Stomach – its related function is to re-
lieve toothache, (4) Toothache 3 – pain relief of the
lower teeth, (5) Jaw – relieves pain in the lower teeth,
tension and anxiety, and (6) Adrenal (suprarenal) –
stimulation of adrenal hormones relieving stress. It is in-
dicated for inflammation and hypersensitivity.
Low-level laser specifications and dosimetry
The red laser diode (Therapy XT® DMC, São Carlos,
Brazil) (ANVISA 80030810157) with a wavelength of
660 nm (±10 nm) will be used. The power of the appli-
ance is 100 mW. The diameter of the fiber optic device
is 600 μm and, thus, a spot (area) of 0.002826 cm2. The
energy delivered per point will be 1 J in 10 s. The radiant
exposure will be 354 J/cm2 and irradiance will be 35.4
W/cm2. In the control side, the device will remain
turned off, so neither the patient nor the surgeon will
know to which side it is really being applied. We asked
DMC (São Carlos, Brazil) to silence the device.
Study variables
All the variables described below will be evaluated by
the same operator at baseline, and 24 h, 48 h and 7 days
after each surgery. The primary outcome will be postop-
erative pain assessed by a Visual Analog Scale (VAS).
Secondary outcomes will be trismus, edema, local
temperature, dysphagia, and presence of infection (sys-
temic temperature, lymphadenopathy).
The pain will be assessed by applying a VAS, consisting of
a 100-mm line numbered in centimeters, with two closed
ends. One end is labeled “0” and the other “100,” meaning
“no pain” and “worst pain already felt,” respectively. Each
patient will be instructed to mark a vertical line with the
point that best matches the intensity of pain during the
evaluation. Instructions on marking will always be given to
the patient by the same operator [29]. These assessments
will be done at baseline, and 24 and 48 h after surgery. The
opposite side of the mouth will be evaluate identically but
after a 21-day interval.
The criteria for the determination of edema will fol-
low preestablished measurements: (1) the corner of
the eye to the angle of the jaw, (2) the tragus to the
labial commissure, and (3) the tragus to the pogonion
[30]; see Fig. 2.
Fig. 1 Auricular acupuncture points. Legend: (1) Shen Men, (2)
Sympathetic (SNV), (3) Stomach, (4) Toothache 3, (5) Jaw, (6) Adrenal
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For the evaluation of the presence of trismus the inter-
incisor measurement (distance between the incisal edge
of the maxillary central incisor and lower) will be used
with a digital caliper (Mitutoyo Digimatic Caliper model,
Kawasaki, Japan). During clinical examination (7 days
before the surgery), the patient will be asked to perform
their maximum mouth opening, which will be measured
in millimeters [31].
The local temperature will be measured in the
mandibular angle region 2 cm above the lower jaw
board (Safety 1st® model “No Touch Forehead”, Col-
umbus, OH, USA).
Fever (systemic) is usually an indicator of infection.
Since, in case of infection pain is usually worse, this may
become a bias. The temperature will be measured using
a digital thermometer (Safety 1st® model “No Touch
Forehead”, Columbus, OH, USA).
The assessment of dysphagia will be conducted
through a numerical scale: 0 – indicates total absence of
dysphagia; 1 – dysphagia for solid food; 2 – dysphagia
for any food, liquid or solid.
Rescue medication intake – the quantity of medicine
ingested will be counted and statistically analyzed. All
patients will be advised to take only acetaminophen in
case of pain. We will ask for tablet return in order to
monitor adherence to intervention protocols. A flow-
chart is presented for an overview of the study (Fig. 3)
Profile of plasma and salivary cytokines
Blood samples will be collected in dry tubes and sent to
the laboratory of Biophotonics Applied to Health Sci-
ences (Nove de Julho University). After centrifugation,
serum will be stored in 1.5-mL tubes at −80 °C. Plasma
levels of inflammatory markers of TNF-α, IL-1, IL-6 and
IL-8 will be quantified using commercial ELISA kits
(Peprotech Inc., Rocky Hill, NJ, USA) according to the
manufacturer’s instructions.
Statistical analysis
The data will be tabulated on an Excel table developed
for research.
By the end of the study, randomized groups will be re-
vealed and statistical analysis will be performed as group
A or group B. The meaning of A or B will be known
after statistical analysis. The data will be evaluated by
comparing the two groups: experimental and control
groups (“gold standard”). Data will be submitted to the
Shapiro-Wilk test to test for data normality. If the data
is normal a homogeneous t test will be applied. For non-
parametric data and scores the Mann-Whitney test will
be applied. Data will be presented as means ± SD and
the p value set at 0.05.
Discussion
This study aims to evaluate the effectiveness of auriculo-
therapy stimulation with laser on postoperative pain in
patients undergoing third molar surgery. The main ra-
tionale for conducting this study is for the reduction of
postoperative anti-inflammatory drug and analgesic use
because of the frequency of adverse effects associated
with their use [8, 9]. Extraction of third molars is consid-
ered the best model for assessing acute pain [32] and
has been used for a long time [33]. To avoid bias, the
two surgeries (experimental side and control side)
should be performed as closely as possible; however, a
time interval between surgeries is necessary to avoid dis-
tortions in patient’s judgement of their pain [34]. There-
fore, it is important to have control variables: surgical
technique, tooth position and variables inherent to the
surgeon. Additionally, the surgical technique should be
standardized as much as possible in order to cause
comparable surgical trauma. The incision should also
be standardized, as should the osteotomy and
odontosection.
Some specific techniques are proposed to evaluate
tooth position. The Winter and the Pell and Gregory
techniques are the most common. Despite the Winter
technique being simpler and more easily reproducible
[35], it does not consider adequate parameters for the
Fig. 2 The criteria for the determination of edema. Legend: (I) The
corner of the eye to the angle of the jaw, (II) The tragus to the labial
commissure, and (III) The tragus to pogonion
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standardization of symmetry between the sides. The Pell
and Gregory technique is more complete [25]. It evalu-
ates the tooth depth position in the vertical direction
(relative to the occlusal plane and in relation to the neck
of the adjacent second molar) and the horizontal (as it
evaluates the position of the tooth in relation to the
ramus of the mandible). In order to classify the position
of a tooth, a panoramic radiograph is usually sufficient.
Teeth should be as symmetrical as possible. The
variables inherent to the surgeon, such as length of pro-
fessional experience, manual dexterity, and level of train-
ing, can be controlled when only a particular surgeon
performs all surgeries. Moreover, the split-mouth tech-
nique allows the patient to be their own control, thus re-
ducing variation between individuals. In this case, it
eliminates factors such as subjectivity of pain, inflamma-
tory response, degree of mouth opening, elasticity of the
buccal mucosa, size of the oral rhyme and anatomical
Fig. 3 Flowchart presenting an overview of the study
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variations between the experimental and control groups,
because the experimental and placebo treatments are
performed on the same person. Also, regarding the simi-
larity of procedures to minimize differences between in-
terventions, the device will remain connected on one
side and turned off on the control side, so that neither
the patient nor the surgeon will know to which side it is
really being applied. This is an important issue because
the device emits sound during its operation. Because of
this, we asked the company which manufactures the
laser to silence the device. For its use, one researcher
will apply the laser, and yet another one will measure
the variables (pain, trismus, edema, local temperature,
dysphagia and presence of infection by means of sys-
temic temperature measurement and assessing the de-
gree of lymphadenopathy).
A red diode laser with a wavelength of 660 nm
(±10 nm) will be used. It has been proved that a
wavelength of 650 to 950 nm can penetrate biological
tissue to a depth of 3 mm [36]. However, some au-
thors believe that a wavelength of 633 to 670 nm is
the best option for laser therapy [15]. For acupunc-
ture, it would be necessary to use a wavelength that
achieves greater depth, since the acupuncture needle
is 15 to 70 mm long, thus in this case a 810-nm
(near-infrared) laser would be more appropriate.
However, for auriculotherapy points, the stimulus
(mustard seeds, needles 1 to 2.5 mm) does not pene-
trate tissue so deeply, so the 660-nm laser (red wave-
length) seems sufficient for our study. For this reason,
we chose the lower wavelength 660-nm laser.
It has been shown that the irradiance required to
achieve the same effect as an acupuncture needle must
be greater than 1.3 W/cm2 [37]. Other authors indicate
radiant exposure of 0.001 J/cm2 to 10 J/cm2 or more
[15]. One of the reasons for choosing auriculotherapy is
for convenience of application as with it there is no need
for the introduction of an intra-appliance tip orally
(Pages-Escobar, 2010; [2, 38]).
The auricular points were chosen based on the
Chinese School [18], as suggested by Oleson [21].
This study followed the Standards for Reporting
Fig. 4 Template of recommended content for the schedule of enrollment, interventions and assessments.* Legend: *Recommended content can
be displayed using various schematic formats. See SPIRIT 2013 Explanation and Elaboration for examples from protocols (Additional file 1)
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Interventions in Clinical Trials of Acupuncture
(STRICTA) recommendations, a new, specific proto-
col for acupuncture studies [39].
Postoperative pain will be our primary variable, so
it is very important to measure it properly. Patients
will always take the same medication regardless of
which side has been operated on. Acetaminophen
will be given to patients because it is a safe and po-
tent analgesic for acute soft tissue pain, showing no
inferiority when compared with NSAIDs [40]. Al-
though the mechanism of action of acetaminophen
has not yet been fully elucidated, it is known that,
as with NSAIDs, it is sufficient for peripheral pain
[41]. The selection of acetaminophen was based in
the parameters recommended by the WHO [42]. All
patients will be advised to take only acetaminophen
in case of pain. At the relevant moment, they will be
encouraged to write down the day, time and pain in-
tensity at the time they decided to take the medica-
tion. In case of severe pain, they will be instructed
to contact the surgeon and begin a regimen of co-
deine plus acetaminophen. If the parameters for
selecting the appropriate analgesics [42] is are not
adhered to, the effect of the treatment could be
masked, and could bias the data, as reported in
other studies [31].
For pain measurement, a VAS will be included as
the main instrument for assessing the patients’ experi-
ence of pain. This scale is graduated in centimeters,
which allows the use of parametric tests, which in
turn improves accuracy of data analysis. Infection pa-
rameters (systemic disease) will also be evaluated.
Such patients will be excluded from the study, but
accounted for and described according to the CON-
SORT statement. The anti-inflammatory drugs and
analgesics have been classically used for treating pain
after third molar surgeries, but they are not exempt
from adverse effects, such as allergies and chronic
gastritis. The association between low-level laser and
auricular acupuncture may be a low-risk alternative to
abolish the need for, or reduce the quantity of, these
postoperative medications.
Trial status section
This trial has not initiated patient recruitment at the
time of submission.
Additional file
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